Germany’s Digital Healthcare Act promises to provide a standard care environment for manufacturers of new digital health tools to evaluate pricing strategies and understand how digital health applications fit into health care practice and patients’ everyday routines.
Not taking prescribed medicines for diseases such as diabetes and hypertension can have a severe impact on health. @kytadhere, an AI-based, digital therapeutics (DTx) app is ensuring you are rewarded every time you take your medicine on time. Find out how
https://t.co/XsUGZmdGbG
They have little or no control over how their data are used. However, regulators in the EU and US are exploring data ownership issues that could significantly change the landscape and give people more rights to dictate how their records are used and potentially share the profits.
Patient records, including direct-to-consumer genetic testing results, are routinely stripped of certain identifying information and sold to aggregators for resale to drugmakers, insurers, health systems and government for research, but most patients are unaware of this.
Ms. Dimple Dang in conversation with Prittle Prattle News on the "Role of Artificial Intelligence in Patient Engagement"
#ArtificialIntelligence#PatientEngagement
https://t.co/frI9VeLxZI
People in the US have become more willing to use telehealth and more comfortable sharing information with health care providers and insurers since the onset of the COVID-19 pandemic, according to a survey by Deloitte.
Patients and clinicians' quick move to telehealth and virtual care, the realization that the technology was available and just needed to be used, and doubts about whether the pace of adoption can be sustained are among the lessons health care leaders are learning in the pandemic.
At least 60% of patients who used virtual care tools said that based on their experience during the pandemic, they want to use technology more for communicating with healthcare providers and managing their conditions in the future.
Patient advocates have long pushed for more virtual trials, which ease the burden of clinical-trial participation. If the trend catches on, it could speed up the enrolment of participants — a significant piece of the drug-development timeline.
While most of the attention and use of digital health for chronic care management has gone to players in diabetes, hypertension and related spaces … there is a growing interest in respiratory conditions, asthma and COPD.
Poor adherence to and persistence with prescription drug regimens constitute an omnipresent and complex problem, especially for chronically ill patients. With patient non-adherence to prescription regimens stuck at nearly 50% #telehealth may offer a path forward.
Three rapid changes in the health care system that are linked to the novel #coronavirus pandemic include greater use of #telehealth, increased concern over the future of primary care, and less emphasis on hospital care.
With the limited face-to-face engagement during the COVID-19 pandemic, patients have increased their use of tele-health and other digital platforms to manage their health which could translate to an increased appetite for more digital engagements now and in the future.
"#DigitalTherapeutics that deliver evidence-based interventions to help prevent, manage or treat medical conditions can play an even more important role during the COVID-19 pandemic, when people are staying at home and not necessarily seeing their providers regularly" AMCP
More and more pharmaceutical organisations are starting to use data to personalise their marketing processes. By using feedback in combination with wider third-party data integrations, companies are able to enhance their consumers’ satisfaction now.